2014
DOI: 10.2478/s11535-014-0352-8
|View full text |Cite
|
Sign up to set email alerts
|

Hepatitis C virus resistance to interferon therapy: an alarming situation

Abstract: Hepatitis C virus is presently a major public health problem across the globe. The main objective in treating hepatitis C virus (HCV) infection is to achieve a sustained virological response (SVR). Interferon-α (IFN-α) and pegylated interferon (PegIFN) in combination with Ribavirin (RBV) are the choice of treatment nowadays against chronic hepatitis C. There are several mechanisms evolved by the hepatitis C virus that facilitate the persistence of virus and further lead the patient’s status as non responder. V… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 93 publications
0
1
0
Order By: Relevance
“… 2 , 4 After being infected with HCV, patients frequently develop liver steatosis pathophysiology 7 and show resistance to interferon (IFN) treatment. 8 , 9 HCV is a lipotropic virus associated with serum lipoprotein. 10 The replication and infectivity of HCV can be regulated by cellular lipid status, 4 making serum lipoprotein level a good candidate marker and therapy for HCV-induced disease progression.…”
Section: Introductionmentioning
confidence: 99%
“… 2 , 4 After being infected with HCV, patients frequently develop liver steatosis pathophysiology 7 and show resistance to interferon (IFN) treatment. 8 , 9 HCV is a lipotropic virus associated with serum lipoprotein. 10 The replication and infectivity of HCV can be regulated by cellular lipid status, 4 making serum lipoprotein level a good candidate marker and therapy for HCV-induced disease progression.…”
Section: Introductionmentioning
confidence: 99%